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The New Delhi metallo--lactamase (NDM-1) was initiallyidentified in clinical isolates of Escherichia coli and Klebsiella
pneumoniae in Sweden from a patient previously hospitalized in
India (1). Since then, blaNDM-1 has frequently been reported in
Enterobacteriaceae and Acinetobacter spp., with a fast dissemina-
tion in the Indian subcontinent, the Balkan countries, China, and
the Middle East (2). NDM-1 producers generally associated with
Enterobacteriaceae species have also been reported, albeit with
much lower frequency, in Latin American countries, including
Guatemala, Mexico, Colombia, and Brazil (3). Moreover, produc-
tion of NDM-1 in this geographic region has also been noted in
Acinetobacter baumannii in Honduras and Brazil (3, 4) and in
Acinetobacter pittii in Paraguay and Brazil (5, 6). Here, we report
the first case of an NDM-1-producing Acinetobacter species in
Argentina, an Acinetobacter bereziniae clinical isolate. We describe
also the complete sequence of a blaNDM-1-containing plasmid in
this strain.
(Part of this work was presented at the 10th International Sym-
posium on the Biology of Acinetobacter 2015, Athens, Greece, 3 to
6 June 2015 [7].)
A. bereziniae HPC229 was isolated on June 2014 from a blood
sample of a 53-year-old female patient that underwent chemo-
therapy due to leukemia at a hospital located in Rosario, Argen-
tina. The patient was treated with ciprofloxacin plus tigecycline,
resulting in clinical and microbiological cure as evaluated by neg-
ative blood cultures. The patient was readmitted to the hospital 3
months later with symptoms of severe sepsis and died due to septic
shock, with positive blood cultures that grew Escherichia coli.
HPC229, originally identified as Acinetobacter lwoffii by the
Vitek 2 system (bioMérieux), was reclassified by DNA sequence
comparison analyses of its 16S rRNA, gyrB (8), and rpoB (9) genes.
The highest identity was found to the corresponding orthologs of
the A. bereziniae ATCC 17924 type strain (99.9%, 99.7%, and
99.8%, respectively). The antibiotic susceptibility profile of
HPC229 was determined by either the Vitek 2 system or the agar
dilution method. The interpretation of the obtained MICs based
on CLSI breakpoints (10) indicated resistance to -lactams, in-
cluding carbapenems (Table 1).
PCR amplification using specific primers for the blaIMP,
blaVIM, blaSPM, blaNDM, blaOXA-23-like, blaOXA-24/40-like, and
blaOXA-58-like genes (11–13) and sequencing analysis revealed the
presence of blaNDM-1. Evidence that blaNDM-1 was located in a
plasmid was first obtained by plasmid curing (14) in which
HPC229 was cultured in 5 ml of LB liquid medium containing 0.2
ml of 10% SDS for 48 h at 40°C. This procedure allowed the iso-
lation of HPC229c, which showed a marked increase in suscepti-
bility to -lactams (Table 1). Susceptibility to aztreonam as
judged by the disk diffusion assay, in contrast, showed no differ-
ences between HPC229 and HPC229c. All conjugation attempts
using HPC229 as the donor and Escherichia coli DH5, A. bau-
mannii ATCC 17978, or Pseudomonas aeruginosa PAO1 as the
recipient (11) were unsuccessful. The genomic relatedness be-
tween HPC229 and HPC229c was confirmed using previously de-
scribed PCR-based procedures (15), and the loss of blaNDM-1 was
confirmed by specific PCR analysis.
Analysis of whole-genome sequencing performed with pyrose-
quencing (454 Genome Sequencer FLX system; Roche Diagnos-
tics) demonstrated that the blaNDM-1 metallo--lactamase gene
was located in HPC229 in a 44,560-bp plasmid, designated
pNDM229. This gene was found located inside a composite trans-
poson bracketed by two copies of ISAba125 and identical to that
first described in A. baumannii (16) and designated Tn125 by
Poirel et al. (17). The immediate genetic environment of Tn125 in
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TABLE 1 Antimicrobial susceptibilities of A. bereziniae HPC229 and its
plasmid-cured HPC229c derivativec
Antimicrobial(s)
MIC (g/ml)
HPC229 HPC229c
Ampicillin-sulbactama 16 2
Ceftazidimeb 256 8
Cefotaximea 64 8
Cefepimeb 256 1
Piperacillin-tazobactama 128 8
Imipenemb 128 0.125
Meropenema 16 1
Colistina 0.5 0.5
Gentamicina 1 1
Amikacina 2 2
Trimethoprim-sulfamethoxazolea 20 20
Ciprofloxacina 0.5 0.5
a MICs were determined by the Vitek 2 system.
b MICs were determined by the agar dilution method.
c HPC229 was resistant to ampicillin-sulbactam, ceftazidime, cefotaxime, cefepime,
piperacillin-tazobactam, imipenem, and meropenem, and it was susceptible to colistin,
gentamicin, amikacin, trimethoprim-sulfamethoxazole, and ciprofloxacin according to
CLSI breakpoints (10).
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pNDM229 is most similar to that of the conjugative plasmid
pNDM-BJ01 (18) present in an A. lwoffii clinical strain (Fig. 1). In
both cases, the Tn125 element is located immediately downstream
of an aphA6 gene, which is in turn adjacent to an upstream
ISAba14 insertion sequence. In the case of pNDM229, however, a
second ISAba14 copy was found immediately downstream of the
Tn125 element (Fig. 1), thus representing a novel difference from
the similar arrangements previously reported (18, 19). This sug-
gests the evolution of a novel composite transposon now bounded
by two ISAba14 elements with the potential ability to mobilize as a
whole.
In summary, we describe here the first case of an NDM-1-
producing A. bereziniae isolate in Argentina. To our knowledge,
only one other A. bereziniae NDM-1-producing clinical isolate has
been recently reported (CHI-40-1), and the blaNDM-1 gene was
located in this strain in a conjugative plasmid (19). However, a
number of differences were noted between HPC229 and CHI-
40-1 and between the plasmids carried by them (Fig. 1). First,
comparison analyses of the corresponding 16S rRNA, gyrB, and
rpoB genes revealed identities of 99.9%, 99.8%, and 99.6%, respec-
tively, indicating no immediate clonal relationship between these
two A. bereziniae strains. Second, comparison of the correspond-
ing blaNDM-1-containing platforms revealed two deletions in
pNDM-40-1 which were not observed in pNDM229, one of which
removed 1,298 bp from the 3= end of ble to dsbC and the other of
which removed 150 bp within insE (Fig. 1). Third, the above-
noted second copy of ISAba14 downstream of Tn125 was present
only in pNDM229. Fourth, unlike with other conjugative plas-
mids, such as pNDM-40-1 and pNDM-BJ01, some conjugation-
related genes, including virD4, trg, virB11, virB8, virB10, and
virB9, were either truncated or absent in pNDM229 (Fig. 1), thus
explaining conjugation failures.
The origin of A. bereziniae HPC229 remains obscure, since no
history of overseas travel of the compromised patient or direct
contact with foreigners could be identified. The above findings
represent a worrisome concern, especially when considering that
Acinetobacter species other than A. baumannii can act as reservoirs
of blaNDM genes and most probably contribute to their spreading
among clinically relevant Enterobacteriaceae species (6, 19).
Nucleotide sequence accession numbers. The 16S rRNA,
gyrB, and rpoB sequences of the HPC229 strain used for com-
parison with other Acinetobacter species have been released in
GenBank under the accession numbers KP765739, KP765740,
and KP765741, respectively. The 44,560 bp blaNDM-1-containing
pNDM229 plasmid sequence has been released under accession
number KT072713.
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